McDermott Will & Emery LLP
McDermott Will & Emery is a premier international law firm with a diversified business practice. Our personalized medicine practice features a unique blend of legal, policy, legislative and communications expertise that includes our medical products/government strategies, life sciences, intellectual property and health information technology practices. We promote a team approach to strategy development and problem solving and our personalized medicine practice is compromised of subject matter and technical experts including lawyers who have served in high level government positions at key federal agencies and departments such as the FDA, HHS, and DOJ, as well as on Capitol Hill. McDermott advises diagnostic manufacturers, pharmaceutical and biotechnology companies, laboratories, investors, coalitions and others on a broad spectrum of issues including FDA and CLIA regulatory policies, legislative strategies, product approval, clearance and compliance issues, research and clinical data development and analysis, outcomes and comparative effectiveness research, adverse event reporting and crisis management, business strategy and communications, investor due diligence, coalition building, marketing and promotional issues, third-party payor reimbursement coverage, coding, billing and payment issues, government investigations and enforcement, intellectual property procurement and enforcement, conflicts of interest, and review, analysis and response to technical assessments.